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Molecular biomarkers to assess health risks due to 
environmental contaminants exposure
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Biomarkers, or bioindicators, are metric tools that, when compared with reference values, allow 
specialists to perform risk assessments and provide objective information to decision makers 
to design effective strategies to solve health or environmental problems by efficiently using the 
resources assigned.
Health risk assessment is a multidisciplinary exercise, and molecular biology is a discipline that greatly 
contributes to these evaluations because the genome, transcriptome, proteome and metabolome 
could be affected by xenobiotics causing measurable changes that might be useful biomarkers. Such 
changes may greatly depend on individual genetic background; therefore, the polymorphic distribution 
of exposed populations becomes an essential feature for adequate data interpretation. 
The aim of this paper is to offer an up-to-date review of the role of different molecular biomarkers in 
health risk assessments.
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epidemiology.
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Biomarcadores moleculares para evaluar el riesgo para la salud debido a la exposición a 
contaminantes ambientales
Los biomarcadores, o bioindicadores, son herramientas métricas que, al compararse con los valores 
de referencia, permiten evaluar los riesgos y generar información objetiva que ayude a las autoridades 
a planificar estrategias efectivas, solucionar problemas de salud o ambientales y utilizar los recursos 
asignados de manera eficiente. 
La evaluación de riesgos en salud es un ejercicio multidisciplinario y la biología molecular contribuye 
enormemente a estos estudios, dado que el genoma, el transcriptoma, el proteoma y el metaboloma 
pueden verse afectados por xenobióticos, lo que causa cambios cuya medición resulta útil en la 
adopción de decisiones. Dichos cambios pueden variar por la carga genética de cada individuo y 
su distribución polimorfa en las poblaciones expuestas se convierte en un factor esencial para una 
adecuada interpretación de resultados.
Por lo tanto, el objetivo del presente artículo fue hacer una revisión de los diferentes biomarcadores 
moleculares aplicables a la evaluación de riesgos para la salud provenientes de los contaminantes 
ambientales.
Palabras clave: marcadores biológicos, medición del riesgo, contaminantes ambientales, biología 
molecular, epidemiología molecular.
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Indicators or biomarkers
Indicators or markers are widely used metric tools 
that assess the degree of agreement or accomplish-
ment of qualitative or quantitative data with respect 
to a given reference value. Specialists and the 
general public routinely apply them in practically 
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all fields, such as economics, development, poli-
tics, academics and health. Indicators provide 
precise and specialized information to the general 
population and/or professionals to acquire an 
accurate perception of specific issues on the status 
of society or on personal performances. Changes 
in specific indicators can be used to estimate 
the status of a system and assess its evolution, 
progress, improvement or risk; then, indicators 
provide the basis to implement political changes 
or for informed decisions towards the efficient 
achievement of particular goals.
In Biology and Health Sciences, the US National 
Academy of Sciences defined biomarkers as 
“cellular or biochemical components or processes 
altered by a xenobiotic; those changes can be 
measured in the entire system or in a biological 
sample” (1). Thus, according to biochemistry or 
physiology, reference values of certain metabolic 
activities or physiological functions are used to 
assess the health status of an individual. Based on 
biomarker data, the extent of changes caused by 
internal or external factors can be assessed and 
used to design strategies to solve such situations.
The environment and health issues
The need to know the incidence of disease and 
its etiology, particularly due to environmental 
occupational exposures, started with Bernardino 
Ramazzini (1633-1714), an Italian physician from 
Padova, who successfully associated occupational 
environmental exposures with specific pathologies. 
In his book “De morbis artificum diatriba” (1700), 
he associated 54 work activities with illnesses. The 
book was the first attempt to systematically classify 
diseases according to the chemicals present in the 
work environment and the pathologies developed 
(2). Presently, biomarkers are used as specialized 
parameters to assess particular conditions in a cell 
up to a population. Biomarkers are useful to make 
informed decisions at all levels –they are necessary 
to implement policies aimed at solving challenges 
or preventing situations efficiently. However, bio-
markers should be reliable and opportunely available 
to decision makers.
Biomarkers characteristics
Biomarkers are classified as biomarkers of 
exposure, effect or susceptibility (3) (figure 1). 
Each one is useful to assess the health status of 
an individual, a population or even an ecosystem. A 
biomarker can be used alone; however, sometimes 
biomarkers of different types need to be analyzed 
jointly because some of them may not be highly 
specific and may require correlation with other 
parameters for adequate interpretations. 
To be considered reliable, a good biomarker should: 
a) Respond to a biologically active contaminant, 
b) have a dose-effect response correlated with the 
contaminant levels, 
c) have a response that persists even if the exposure 
to a pollutant ceases because the compound may 
not remain indefinitely in the environment,
d) preferably be non-invasive in the case of humans 
and should be easily measurable, and 
e) be specific so that an effect can be attributed to 
a chemical, thus contributing to the certainty of an 
assessment, and sensitive because the biomarker 
response should be related to the amount of 
toxicant capable of eliciting an effect. 
These parameters indicate the biological and 
environmental relevance of pollutant concentrations 
(4) (figure 2).
Blood is the preferred tissue to analyze biomarkers; 
its collection is of low invasiveness, and it is a 
readily available tissue that contains different 
cell types (erythrocytes and lymphocytes) and 
fluids (plasma). One of its characteristics is that it 
distributes nutrients, collects metabolic products 
that carry information among organs, or serves as 
vehicle for their excretion. However, blood has its 
own features, cells belong to different lineages, 
and metabolites come from different organs. When 
blood or blood cells are used as surrogates for 
other tissues, toxicity and risk assessment results 
are obtained faster than with solid tissues, and the 
physiological changes in organs or fluids may be 
reflected by changes in the blood. In other words, 
changes in blood measurements should be closely 
correlated with the effects in the parent organ.
Adequate biomarkers are necessary to develop a 
successful biological monitoring program, and the 
following steps should be taken: 
a) Select a biomarker that fits with almost all criteria 
of reliability; 
b) delimit the size of the biological sample to be 
studied in terms of the sensitivity and specificity of 
the biomarker; 
c) consider all confounding factors that may alter 
results, as well as co-exposure to other chemical 
agents, and 
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d) select the appropriate tissue for analysis. 
The results will reflect the total burden of chemical 
agents that enter into an individual through all 
body routes.
Biomarkers of exposure
A biomarker of exposure refers to the quantitation 
of a parent compound or its metabolites in a tissue 
or body fluid, or the reaction product(s) of any of 
those with a biological molecule (4). According 
to this definition, biomarkers of exposure can be 
classified into: 
1) Markers of internal dose, which indicate the con-
centration of a given pollutant in an organism, and 
2) markers of effective dose, which indicate the 
extent of the interaction of a pollutant with a target 
molecule (figure 3). 
A brief summary of the methods used to study 
several types of common biomarkers, surrogate 
tissues for analysis and environmental factors that 
modify their levels is shown in table 1.
Biomarkers of internal dose
Because direct determinations of environmental 
pollutants do not necessarily reflect the biologically 
available concentrations in an organism, the evalua-
tion of internal doses becomes necessary to assess 
the current exposure status in terms of the quantity 
of the parent compound or its metabolites present 
in the body fluids or tissues of exposed individuals 
or populations (4). Some metabolic products from 
the biotransformation of a xenobiotic are useful 
biomarkers of internal dose. The environmental 
or occupational exposure to polycyclic aromatic 
hydrocarbons (PAH) can be monitored by the 
quantitation of metabolic intermediates of frequent 
and abundant chemicals in the mixture, such 
as 1-hydroxypyrene (1-OHP), the main pyrene 
metabolite (90%), with an average half-life of 
approximately 18-20 hours after pyrene inhalation 
(5). Urinary 1-OHP is routinely used as a biomarker 
in workers occupationally exposed to PAHs (6-8), 
tobacco smokers (9,10) and the general popula-
tion exposed to airborne pollution (11-13). Urinary 
1-OHP is readily measured by high performance 
Biomarkers
Exposure
Internal dose
1-OHP
1- and 2-NT
OHPhe
1-pyrenol
DNA-adducts
Protein-adducts
Oxidized
nucleobases
Chromosomal
aberrations
Micronuclei
Sister chromatid
exchanges
MicroRNAs
Transcription
regulation
Somatic cell
mutations
DNA
methylation
Histone
modifications
DNA repair
XRCCs, OGG, XPC
Phase I ME
CYP, EPHX1, AKRs
Phase II ME
NATs, GSTs
DNA damage
Effective dose Cytogenetic Genetic Epigenetic Polymorphisms
Effect Susceptibility
Figure 1. Classification of biomarkers
1-OHP: 1-hydroxypyrene; AKRs: aldo-keto reductases; CYP: cytochrome P450 enzymes; EPHX1: epoxide hydrolase 1; GSTs: 
glutathione S-transferases; ME: metabolizing enzyme; NATs: N-acetyltransferases; NT: naphthol; OGG: oxoguanine DNA glycosylase; 
OHPhe: hydroxyphenanthrenes; XPC: Xeroderma pigmentosum - C; XRCCs: X-ray cross-complementing
Biomarkers
characteristics
Non-invasive and
easy measurable
Specific and
sensitive
Respond to
the exposure
Persistent
response
Dose-effect
response
Figure 2. Requisites that a biological response should comply 
to be considered as a biomarker for health assessment
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Table 1. Biomarkers of exposure. Environmental compounds that modify the listed biomarkers of exposure, the main methods for 
their identification and the biological samples used for analysis
Biomarkers of exposure
Environmental compounds Methods for identification Types of samples
Biomarkers of internal dose
1-OHP 
1- and 2-NT
OHPhe
1-pyrenol
PAHs
Tobacco smoking
Airborne pollution
HPLC-FD
GC/MS
Urine
Biomarkers of effective dose
DNA-adducts PAHs
Metals
Tobacco smoking
Traffic pollution
MS
Immunoassay
Immunohistochemistry
32P-postlabeling
White blood cells
Lung tissue
Protein adducts Air pollution
Heterocyclic amines
PAHs tobacco smoke
Immunoassays
HPLC-FP
GC/MS
Serum albumin
Hemoglobin
Oxidized nucleobases
(8-oxoGua, 8-oxodG)
Environmental pollution
Metals (Cd, As, Co, Cr, V)
PAHs
PM
Immunoassay
Immunohistochemistry
MS
Chromatography
32P-postlabeling
FPG-based methods
Urine
White blood cells
Tissue (lung, nasal epithelia)
Urine
DNA damage Air pollution
PAHs
PM 
Comet assay
(Endonuclease III, FGP, AlkA)
DNA repair test
In vitro comet repair assay
Peripheral lymphocytes
Leukocytes
Epithelial cells
Sperm
1-OH: 1-hydroxypyrene; 8-oxodG: 8-oxo-7,8-dihydro-2ˈ-deoxyguanosine; 8-oxoGua: 8-oxo-7,8-dihydroguanine; FPG: formamidopyrimidine DNA 
N-glycosylase; GC/MS: gas chromatography coupled to mass spectrometry; NT: naphthol; OHPhe: hydroxyphenanthrenes; PAHs: polycyclic aromatic 
hydrocarbons; HPLC-FP: high performance liquid chromatography with fluorescence detection; PM: particulate matter
Environmental pollution
Biomarkers of exposure
- Biomarkers of internal dose
- Biomarkers of effective dose
DNA-adducts
Single-strand
break
DNA
damage
Oxidized
nucleobases
8-oxodG 8-oxoGua
Double-strand
break
Abasic site
1-OHP 1-NT
OH
HO
OH
N N
NH2
NH
NH
N
H
N
H
N NH
NH2
O
O
O
O
O
OH
OH
2-NT
Protein adducts
Figure 3. Biomarkers of exposure. The biomarkers of exposure are classified as markers of internal dose and markers of effective dose. 
1-OHP: 1-hydroxypyrene; 8-oxodG: 8-oxo-7,8-dihydro-2’-deoxyguanosine; 8-oxoGua: 8-oxo-7,8-dihydroguanine; NT: naphthol
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liquid chromatography with fluorescence detection 
(HPLC-FD), and/or gas chromatography coupled to 
mass spectrometry (GC-MS); its quantitation has 
shown a good correlation with PAH human exposure 
at both high and low environmental levels (5).
Other examples of internal dose biomarkers for 
environmental contaminants are 1- and 2-naphthol 
(NT), naphthalene metabolites that have been 
proposed as PAH biomarkers of air or inhalation 
exposure (14-16); phenanthrene hydroxylated 
metabolites (OHPhe), which are considered good 
biomarkers for occupational PAH exposure (10), 
and 1-pyrenol, another pyrene metabolite, which 
is less frequently used because its concentration 
does not necessarily correlate with the levels of 
exposure to carcinogenic PAHs (17).
Biomarkers of effective dose
Biomarkers of effective dose indicate the inter-
action of a chemical with a biological target, such 
as DNA and proteins, or its damaging effect to a 
biological molecule. Considering that there may 
be substantial inter-individual variations in the 
metabolism of the compounds, the determination 
of the effective dose is required for the evaluation 
of the health effects of pollutants in organisms 
(4). The classical biomarkers of effect determined 
by the exposure to chemical pollutants are DNA 
and protein adducts; the levels of DNA oxidized 
nucleobases and DNA damage.
DNA adducts. A DNA adduct is the product of 
covalent binding of a small electrophilic chemical 
compound to DNA (18). The nature of the 
electrophilic moiety of the DNA adduct can be a 
parent compound or a product of its metabolism. 
Although DNA adducts are targets of multiple DNA 
repair enzymes, some modifications may persist 
and produce several undesirable effects, such as 
nucleotide substitutions, leading to DNA mutations 
and synthesis of altered protein products (19). Many 
environmental air pollutants (20), tobacco smoke 
(20-22) and PAHs from traffic exhaust (23,24) or 
from occupational exposure (21) have shown a 
positive correlation with DNA adduct formation in 
exposed populations. For further information, see 
reference (25).
DNA adducts have been assessed and quantified 
in almost all human tissues, but the preferred 
samples of study are white blood cells due to their 
availability, and lung tissue because the lung is the 
point of entry for most carcinogenic environmental 
contaminants (26). DNA adducts are evaluated 
by three main methodological approaches, all 
characterized by their sensitivity, specificity, cost 
and instrumentation (19). Mass spectrometry (MS) 
is the most specific methodology and is able to 
identify DNA adducts according to their molecular 
weight. This is a high-throughput platform that 
allows the identification of several adducts in a 
sample. However, DNA adduct determination by MS 
requires complex instrumentation and is expensive. 
Immunoassays and immunohistochemistry are tech-
niques that use antisera to identify specific DNA 
adducts in DNA samples or directly in the studied 
tissues. These are low-cost and high-throughput 
assays with the limitation that the adduct species 
to identify are restricted by the availability of 
specific antisera; therefore, the discovery of new 
adducts using these methodologies is not possible. 
32P-postlabeling includes DNA digestion and radio-
active labeling, and then normal and modified 
DNA molecules are separated by chromatographic 
techniques. Despite the fact that this methodology 
is unable to elucidate the structure of DNA adducts, 
only the DNA adduct profile of the sample, it is 
the approach of choice in several studies on DNA 
damage caused by environmental pollution at very 
low exposure levels (27,28). According to Poirier 
et al. (19), approximately 40 different DNA adducts 
have been identified in human samples using the 
aforementioned techniques. 
Protein adducts. Protein adducts are the product of 
a covalent interaction between a reactive chemical 
compound and a protein. The most common protein 
adducts evaluated are those formed with serum 
albumin [particularly with cysteine at position 34 
(Cys34)] and hemoglobin; these proteins are found 
in very large quantities in blood that react with 
electrophilic compounds via their reactive carboxyl, 
amino and/or sulfhydryl groups (29). The study of 
protein adducts as surrogate markers of effective 
dose offers the advantages that proteins often 
have longer half-lives than other markers (parent 
compound or its metabolites), they are much 
more abundant than DNA adducts, and they are 
not subjected to repair (29). The methodological 
approaches employed for protein adducts research 
are based on the number of samples, time, and 
available methodologies. For large-scale studies, 
immunoassays are recommended, but chroma-
tographic-based techniques, such as HPLC-FP or 
GC-MS, are also suitable.
The protein adducts assessed in environmental, 
smoking-related or occupational exposure to PAHs 
are those formed with benzo[a]pyrene (BaP) or the 
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carcinogenic metabolite of BaP (r-7,t-8-dihydroxy-
t-9,t-10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene), 
BPDE. BaP and BPDE form adducts with serum 
albumin and hemoglobin. BaP protein adducts 
are well correlated with smoking, but the adduct 
levels showed only a marginal association or 
even no association at all with environmental PAH 
exposure (30). Moreover, BaP adducts have been 
found at higher levels in people living in rural or 
suburban areas than in subjects from urban 
residences, possibly due to the heat generation by 
organic combustion in the former regions (28,30). 
Interestingly, no association of protein and DNA 
adducts has been observed in studies that evaluate 
the exposure to rural and urban air pollution, which 
was attributed to differences in half-life, kinetics and 
methodological approaches for both markers (28).
Oxidized nucleobases. The production of reactive 
oxygen species (ROS) in aerobic organisms is a 
natural and ubiquitous process associated with cell 
metabolism (31). Different enzymatic pathways 
are dedicated to maintenance of the correct 
balance between pro-oxidative and anti-oxidative 
status, but some exogenous stimuli may shift this 
equilibrium and induce a pro-oxidant condition 
that can damage cell integrity. As is well known, 
ROS are able to modify the DNA nucleobases and 
generate mutations when those are not repaired 
by the corresponding mechanisms (25). Although 
a wide number of oxidative modifications of DNA 
have been described, the oxidation of guanine 
generates 8-oxo-7,8-dihydroguanine (8-oxoGua) 
and its deoxynucleoside, 8-oxo-7,8-dihydro-2ˈ-
deoxyguanosine (8-oxodG), which are the most 
commonly measured products of oxidative DNA 
damage (31). Modified guanine products originate 
from direct oxidation of guanine in double-stranded 
DNA or by the modification of dGTP to 8-oxo-dGTP 
in the general pool of nucleotides in the cell, which 
is then incorporated in the DNA during duplication 
or repair (32). The main repair mechanism of 
guanine-oxidized lesions is mediated by the 
enzyme oxoguanine DNA glycosylase 1 (OGG1) via 
the excision of 8-oxoGua from the DNA (31), with 
the final product released in the urine. However, 
other minor repair systems have been described 
(32). If the corresponding repair system fails in the 
removal of 8-oxoGTP, it results in mutagenesis due 
to the production of GC→TA transversions during 
DNA replication (33).
The level of guanine-oxidized products is mainly 
determined in leukocyte DNA and in urine, even 
though it has also been detected in different 
tissues, such as nasal epithelia. Despite the fact 
8-oxoGua is the major product of DNA repair, the 
determination of 8-oxodG is preferred because 
there are many standardized and validated methods 
for 8-oxodG determination by chromatographic 
methods and by commercial ELISA kits (32). 
Moreover, the 8-oxoGua product is less stable than 
its deoxynucleoside counterpart, which makes its 
extraction, separation and detection difficult (32).
In general terms, the levels of 8-oxodG in a given 
organ or tissue reflect the oxidative state in that 
particular sample, whereas the levels of 8-oxodG 
in urine is a measure of the oxidative damage in the 
whole organism (32). The detection and analysis 
of 8-oxodG is accomplished by chromatographic 
approaches, mainly HPLC with electrochemical 
(EC) detection (HPLC-EC), GC-MS and liquid 
chromatography tandem mass spectrometry (LC/
MS-MS); immunoassays and immunohistochem-
istry; 32P-postlabeling, and the formation of strand 
breaks by the removal of 8-oxodG with the use of 
formamidopyrimidine DNA N-glycosylase (FPG) 
(31,32). 
Many environmental pollutants have the ability to 
induce ROS production, such as particulate matter 
(PM), traffic-related contaminants, wood smoke and 
heavy metals, among others (25,32,33). Overall, 
there is strong evidence that there is an association 
between environmental air pollution and the urinary 
excretion of 8-oxodG or 8-oxoGua, biomarkers that 
are widely used to assess endogenous oxidative 
DNA damage (25).
DNA damage: comet assay. The comet assay or 
the single cell gel electrophoresis assay is an easy, 
fast and sensitive method to evaluate DNA transient 
damage at the level of single- and double-stranded 
breaks, abasic sites, and DNA replication and repair 
intermediates. DNA is isolated from the rest of the 
cell components with a high saline solution with 
detergents in a gelatin-covered slice. The obtained 
DNA is incubated in an alkaline media to unwind 
DNA with strand breaks and then it is subjected 
to electrophoresis. The broken DNA portions will 
migrate towards the anode resembling a “comet 
tail” and are visualized with a fluorescent DNA-
binding dye (34,35). In general terms, the more 
DNA damage the longer the DNA tail. Modifications 
of the basic comet assay include the use of lesion-
specific enzymes for the identification of modified 
nucleobases to increase the specificity and sensitivity 
of the method (34). Usually, the endonuclease III 
enzyme is selected to detect oxidized pyrimidines, 
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FPG for 8-oxoGua identification (oxidized purines) 
and AlkA for alkylated bases (35). Other variants 
of the traditional comet assay are the DNA repair 
test and the in vitro comet repair assay. The former 
measures the DNA repair kinetics and the degree 
of repair after a genotoxic cellular stimulus and 
the latter, the capacity of cell extracts to repair 
damaged DNA (35).
The comet assay is considered a highly sensitive 
assay, and its results correlate well with other 
cytogenetic tests, such as micronucleus (MN), sister 
chromatid exchange (SCE) and chromosomal 
aberration (CA) analysis (34). The preferred bio-
logical material for the comet assay comes from 
isolated peripheral lymphocytes or leukocytes, but 
other type of cells have been used satisfactorily, 
such as epithelial cells obtained from the mouth, 
nose and tear ducts, exfoliated bladder cells, and 
sperm, all of them appropriate surrogate tissues for 
those directly affected by chemicals (36). Moreover, 
in the case of air contamination, the tissue of choice 
is the nasal epithelia because the nose is the point 
of entry of the air pollutants, and these cells have 
shown great sensitivity in sensing environmental 
xenobiotics (34).
The application of the comet assay in human 
biomonitoring for environmental and occupational 
exposure to genotoxic agents has been extensively 
reviewed (34,36). Briefly, the majority of the studies 
reveal a good correlation between exposure to 
environmental pollution and DNA damage, as well 
as associations with the results obtained from 
other biomarkers of exposure (36). For example, 
occupational exposure to carcinogenic PAHs 
reduced the ability of cells to repair damaged DNA 
(37), and the environmental exposure to PM10 
from the emissions of an oil refinery increased DNA 
damage in lymphocytes obtained from exposed 
subjects (38). Moreover, in buccal epithelial cells 
from women chronically exposed to biomass 
smoke, there was a positive correlation between 
PM10 and PM2.5 indoor levels and DNA damage 
(39). Tobacco smoke effects on DNA integrity 
are, in contrast, a controversial issue due to the 
increased, synergistic, discrepant or null effects 
observed in several studies. While in some studies 
there was a strong association of DNA damage 
with tobacco smoking, in others there was only an 
effect in conjunction with other genotoxic agents, 
and in others, the effect was greater in control 
groups compared with exposure groups (with co-
exposure with other chemicals) or there was no 
association (34,40). 
Biomarkers of effect
The presence of chemical contaminants or adverse 
agents in the environment will induce physio-
logical and biochemical changes in a living being, 
and such changes are used as biomarkers of 
effect. These alterations must be a response to 
a chemical exposure and are manifested as the 
regulation, overexpression or inhibition of a specific 
behavioral, biochemical, anatomical, physiological 
or molecular function (27). Biomarkers of effect 
assess the levels of genetic damage in DNA and 
chromosomes, alteration of enzymatic activity, 
gene transcription, and/or gene mutation as well as 
epigenetic modifications, among others. In terms 
of this review, the molecular biomarkers of effect 
will be divided into three categories: cytogenetic, 
genetic and epigenetic biomarkers, which are 
summarized in figure 4 and table 2.
Cytogenetic biomarkers 
The evaluation of cytogenetic biomarkers consti-
tutes the first-choice tool in the assessment of 
human exposure to different agents, as contact with 
environmental pollutants is a common area of study 
(41). The cytogenetic assays that have been widely 
and extensively used involve the determination of 
CAs and MN, but other approaches have been 
used successfully, such as the determination 
of SCEs. Nevertheless, cytogenetic biomarkers 
are unspecific to the type of agent of exposure, 
and there are many confounding factors, such as 
age, cigarette smoking, gender, and irradiation 
exposure, that should be considered to reach 
correct conclusions (42).
Chromosomal aberrations. The alteration of the 
normal arrangement of chromosomes by deletions, 
duplications or reorganizations of the genome that 
can be visualized microscopically is defined as a 
chromosomal aberration (CA) (25,43). Double-
stranded breaks of DNA (DSB) are the main source 
for CAs and are naturally produced during DNA 
synthesis by the accumulation of single stranded 
breaks through excision DNA repair, oxidative 
DNA modifications, and other processes or by 
external stimuli, such as UV and ionizing radiation, 
mutagens, antibiotics or nucleases (43). DSBs are 
generally repaired by three different mechanisms 
in eukaryotes: Homologous recombination repair 
(HRR), single-strand annealing and non-homologous 
DNA end joining. If DSBs in DNA are left unrepaired, 
the chromosome remains broken and leads to 
cell lethality. On the other hand, if the DNA repair 
mechanisms fail in the correct reestablishment of 
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the genetic information, it may generate rearrange-
ments, mutations and cell transformation (43).
The microscopic evaluation of structural CAs 
relies on staining chromosomes using different 
techniques. Human lymphocytes are cultured 
(metaphase or interphase), and chromosomes are 
stained mainly by three different techniques: solid 
staining, chromosome banding and fluorescence 
in situ hybridization (FISH). Solid staining, which 
consists of labeling the chromosomes with only one 
color, is a very limited method that only allows for 
the identification of dicentric and acentric products 
of asymmetrical exchanges, underestimating the 
genetic damage of the cell (43). Moreover, as 
asymmetric exchanges are lethal to cells, the 
cytogenetic assessment can only be performed 
during a short period of time due to the instability 
of the aberrations (44). The chromosome banding 
technique consists of different chromosomal 
banding stains, such as Giemsa staining (G- 
banding), reverse Giemsa (R-banding) staining, 
centromeric (heterochromatin) (C-banding) or multi-
colored banding stain with hybridization labels for 
specific regions of the chromosome (mBANDs). 
Chromosome banding identifies all types of struc-
tural arrangements, including intrachromosomal 
exchanges (that cannot be identified by FISH), but 
this methodology is time consuming and demands 
a skillful analyzer (41,44), which is a disadvantage 
in large-scale studies. In contrast, FISH is the most 
powerful technique and uses chromosome-specific 
probes, allowing for the detection of complex 
genetic configurations involving several breaks in 
two or more chromosomes in addition to symmetric 
and asymmetric rearrangements (43). Single and 
multicolored FISH protocols increase the number 
of chromosomes “painted,” and the number of 
aberrations identified is increased as well as the 
precision of the analysis (43). The greater specificity 
and speed of this approach allows the evaluation 
of larger quantities of cells, which increases the 
sensitivity of this method for the analysis of low 
frequency aberrations due to low-concentration 
exposures (44). One disadvantage of this method 
is that, to gain specificity, it requires augmenting 
the number of labeled chromosomes (with different 
colors or intensities), making the study costly and 
the analysis complex (41).
Biomarkers of effect
Cytogenetic
Genetic
Epigenetic
Chromosomal aberrations Micronuclei Sister chromatid exchanges
Mitosis
Micronuclei
Daughter cells
Somatic cell mutations
Survive
Incomplete
complementarity
Complete
complementarity
Translation inhibition
Target mRNA
mRNA degradation
mIRNA
RISC complex
miRNAs
AAAA
AAAA AAAA
AAAA
AAAA
6-TG
Normal Inversion
Transcription regulation
Transcription
DNA methylation Histone modifications
Acetylation
Phosphorylation
Methylation
Ubiquitination
RNA
DNA
DNMT
Hypermethylated DNA
Deletion Duplication
Figure 4. Biomarkers of effect. The molecular biomarkers of effect are divided in three main groups: Cytogenetic, genetic and epigenetic.
6-TG: 6-thioguanine; DNMT: DNA methyltransferase 
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The association of environmental pollution with 
cytogenetic damage in exposed populations has 
been discussed in several reports and review papers 
(25,27), which have noted CAs are good biomarkers 
of effect and good predictors of cancer risks (41,44) 
The most suitable cell type for CA assessment in 
humans is the peripheral lymphocyte. This cell 
type offers many advantages: 1) It easily grows 
in vitro; 2) a high number of metaphase cells are 
attainable; 3) it provides a whole perspective of the 
systemic exposure to a chemical; 4) it is a cell type 
with a relatively long life, and 5) it is an abundant 
tissue that does not require invasive methods to 
be obtained (44). In occupational or environmental 
exposure assessments, the most popular technique 
for CA characterization is FISH (41). 
Table 2. Biomarkers of effect. Environmental compounds that modify the listed biomarkers of effect, the main methods for their 
identification and biological samples for their study
Biomarkers of effect
Environmental compounds Methods for identification Types of samples
Cytogenetic
Chromosomal aberrations Traffic pollution
Air pollution
Metals 
Solid-staining
Chromosome banding
FISH
Lymphocytes
Micronuclei Traffic pollution
Air pollution
Metals (As, Cd, Hg)
May-Grünwald Giemsa 
Papanicolaou’s stain
Feulgen stain
Acridine orange stain
Cytokinesis-block MN assay
Lymphocytes
Exfoliated epithelial cells 
Sister chromatid exchanges Traffic pollution
Metals (Cd, Cr, Al, As, Pb, Zn)
BrdUrd incorporation Lymphocytes
Genetic
Transcription regulation PAHs
Airborne particles: DE, 
DEPs, UFP, PM
Tobacco smoking
Gene specific
 RT-PCR
 Northern Blot
Genome wide
 microarrays
Leukocytes
PMCs, lymphocytes
Macrophages
Airway epithelium
Cell lines
Somatic cell mutations (HPRT) Airborne pollution
Tobacco smoke
Autoradiographic assay
Clonal assay
T lymphocytes
Epigenetic
DNA methylation Metals (Ni, Cd, Pb, As)
Ambient air pollution: PM, 
black carbon, sulfates, DEP
PAHs, BaP
Gene specific
 MSP, COBRA
 DNA sequencing
Genome wide
 HPCE, HPLC-MS
 MeDIP
 Microarrays
Fluids: Urine, plasma, sputum
Lymphocytes
Buccal cells
Saliva
Tissue
Histone modifications Metals (Ni, Co, As, Cr)
DEP
PM10
BaP
CSC
Gene specific
 ChIP
Genome wide
 MS, HPLC, HPCE
 Western Blot
 ELISA
 ChIP-on-chip
Cell lines
PMC
Leukocytes
Respiratory epithelia
MicroRNAs Metals (As, Cd, Al, Pb)
PM
DE and DEP
Cigarette smoke
Asbestos
Carbon black
Ozone
BaP
Real time PCR
miRNA microarrays
Sequencing
Cell lines
Primary cell cultures
Peripheral blood leukocytes
Tissue:
Epithelial cells brain, liver
Body fluids:
Serum, plasma, urine and 
sputum
BaP: benzo[a]pyrene; BrdUrd: 5ˈ-bromodeoxyuridine; ChIP: chromatin immunoprecipitation; COBRA: combined bisulfite conversion restriction analysis; 
CSC: cigarette smoke condensate; DE: diesel exhaust; DEP: diesel exhaust particles; ELISA: enzyme-linked immunosorbent assay; FISH: fluorescence 
in situ hybridization; HPCE: high performance capillary electrophoresis; HPLC: high performance liquid chromatography; HPRT: hypoxanthine-guanine 
phosphoribosyltransferase; MeDIP: methylated DNA immunoprecipitation; MS: mass spectrometry; MSP: methylation specific PCR; PAHs: polycyclic 
aromatic hydrocarbons; PM: particulate matter; PMC: peripheral mononuclear cells; RT-PCR: reverse transcription-polymerase chain reaction; UFP: 
ultrafine carbon particles 
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Micronuclei. Micronuclei (MN) are cytoplasmic 
chromosomes or chromosomal fragments that 
have been excluded from the nucleus of both 
daughter cells after cell division. Eventually, the 
omitted fragments or the whole chromosomes 
are enveloped by a nuclear membrane that 
resembles a small nucleus that can be observed 
by light microscopy (45). Two main mechanisms 
of MN induction have been defined: Chromosome 
breakage and disruption of the cell spindle during 
mitosis (44,45). 
Different methodologies are available for MN 
assessment. Routine staining with May-Grünwald 
Giemsa or Papanicolaou’s stain is suitable for 
identification of MNs, but DNA-specific stains such 
as Feulgen or acridine orange are more specific 
(45). These staining methods are routine procedures 
that can be performed and afforded by almost all 
laboratories but are laborious, and scoring may 
be tedious. The automation of MN scoring by flow 
cytometry and image analysis offers to increase the 
efficiency of the evaluation process (41). Recently, 
the most widespread technique for MN assays has 
been the cytokinesis-block MN assay (CBMN). 
CBMN evaluates chromosome abnormalities in 
dividing cultured cells (binucleated) after cell 
division has been blocked with cytochalasin-B, 
a cytokinesis inhibitor. Using this method, other 
parameters of DNA misrepair, telomere end 
fusions, DNA elimination or amplification can be 
measured along with the evaluation of cytostatic 
effects and cytotoxicity in the same assay (46).
CBMN can be combined with other tools such as 
in situ hybridization or immunostaining to provide 
more information about the origin of the MN and its 
content. The identification of a centromeric struc-
ture with antibodies against kinetochore proteins 
would indicate either the presence of one or more 
chromosomes in the MN or its origin by disruption 
of the spindle or other components during mitosis. 
Likewise, the detection of consensus repetitive 
centromeric sequences with pancentromeric 
probes allows the identification of whole or partial 
chromosomes in the MN. Moreover, the use of 
DNA probes directed against specific sequences 
provides clues about the specific chromosome 
contained in a MN (44,46).
Micronuclei assays can be performed in almost 
any cell, but the majority of surrogates come 
from the hematopoietic linage (lymphocytes and 
erythrocytes) and bone marrow. From those, 
lymphocytes are the most widely used because 
micronucleated erythrocytes are only obtained 
from splenectomized subjects; on the other hand, 
the use of bone marrow requires a very invasive 
method. Recently, some studies evaluated MN in 
exfoliated epithelial cells obtained from buccal, 
nasal, urothelial, vaginal or cervical mucosa 
(41,44,46). These surrogates are easy to collect 
and, as they are readily in contact with the genotoxic 
compounds, they are the most vulnerable cells for 
MN appearance (45).
Many agents and stimuli produce MN, such as 
pollutants, chemical drugs, radiation, infections, 
nutritional state and inflammation or even aging (45). 
The validation of the MN assay as a biomarker for 
cancer risk assessment remains to be established 
(44), but some preliminary data has found that MN 
frequency in lymphocytes is a good predictor for 
carcinogenesis (47). Despite its lower predictability 
of cancer, the MN assay was recently substituted 
for CA determination in studies of exposure to 
genotoxicants. MN analysis has been widely applied 
in environmental monitoring, and it is the second 
most preferred method (only after 32P-postlabeling) 
to evaluate exposure to traffic pollution (25), as 
the assessment of PAHs is a popular issue (41). 
Moreover, Demetriou, et al., suggested that there 
is some evidence of an association between MN 
and exposure to air pollutants (25).
Sister chromatid exchanges. The process whereby 
two sister chromatids break and rejoin during 
DNA replication, interchanging genetic material 
at homologous regions, is called sister chromatid 
exchanges (SCE) (44,48). This is a natural process 
in mammalian cells that is associated with DNA 
replication when the two chromatids are tightly 
joined by the centromere, and the mechanism 
underlying its formation involves a single-stranded 
break of DNA. During DNA synthesis, a replication 
fork is formed between the two parental and the 
nascent strands. When a gap is encountered in 
one of them, the replication fork is broken by a DNA 
repair mechanism, and a 3ˈ single-stranded break 
forms. The replication fork is restored likely by HRR 
with the exchange of specific DNA regions between 
both chromatids (48).
SCE is microscopically analyzed using the thymidine 
analog 5-bromodeoxyuridine (BrdUrd). BrdUrd is 
added to the cell culture and incorporated during 
the first two rounds of DNA replication. During 
the first replication, each original DNA strand 
is duplicated with a daughter strand containing 
BrdUrd. During the second round, the original 
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DNA strand will be again duplicated with a BrdUrd-
containing strand, but the other strand will be 
double labeled. Therefore, both sister chromatids 
can be visualized and distinguished with a staining 
procedure, such as fluorescence plus Giemsa 
staining, acridine orange followed by Giemsa 
staining, or with the use of anti-BrdUrd-labeling 
counter-stained with DAPI or propidium iodide (48-
50). Exchanges are recognized by the interchange 
of physical regions from one chromatid to the other. 
The ease of analysis has made this assay popular 
for the assessment of the genotoxic potential of 
chemicals with the consequent generation of large 
SCE databases (44).
SCEs are evaluated in any cell that can be 
maintained in culture for two duplication cycles 
in the presence of BrdUrd (44), and by far, human 
peripheral blood lymphocytes are the cell type most 
widely used for this purpose. Although SCE assays 
have been extensively used for the determination 
of the genotoxicity of multiple compounds, some 
evidence suggests that it is not a reliable biomarker 
of cancer risk; nevertheless, it can be used as a 
valuable tool for the assessment of cytogenetic 
damage in exposed individuals, as well as a 
biomarker of exposure (44). The effect of ambient 
pollutants, such as exposure to traffic exhaust, has 
been assessed and reviewed previously (51).
Genetic biomarkers
Transcriptional regulation. The gene expression 
induction by diverse stimuli reflects the biological 
response of the cell to the stimulus. In the case 
of exposure to environmental pollutants, the 
transcriptional profile of a given cell or organism 
indicates the defense mechanisms activated, the 
minimal dose at which the effect is observed, and 
the time window of gene induction or repression, 
as well as the signaling pathways involved in the 
process. Therefore, the knowledge of the repertoire 
of genes transcribed under a given circumstance aid 
in the dissection of the mode of action of toxicants. 
The available methodologies to assess gene expres-
sion profiles include high-throughput platforms, 
such as cDNA microarrays, and gene-specific 
methods, i.e., RT-PCR or Northern blots. Microarray 
analysis is, by far, the preferred methodology, 
and this procedure includes total RNA extraction 
and cDNA synthesis for microarray hybridization. 
Subsequently, the validation of the results is 
performed by real-time RT-PCR of specific genes 
of interest.
The transcript profile can be evaluated in multiple 
types of samples, with availability depending on 
the model of study. In the case of animal models, 
the transcriptome can be determined from any 
type of tissue or fluid, while in human studies, 
the use of subrogate tissues, such as peripheral 
blood lymphocytes (PBL) (52) or leukocytes (53), 
is preferred. Accordingly, Siravastava, et al., noted 
that PBLs (54) and peripheral blood mononuclear 
cells (PBMC) (55) are appropriate models to study 
the effect of diesel exhaust particles (DEP) in animal 
airways due to the similarities in gene expression 
patterns in comparison to lung tissue. However, 
human B lymphocytes (56), alveolar macrophages 
(57), and airway epithelium (58) have also been 
used in several reports. Another alternative is the 
use of cell lines, which serve as models of lung, 
liver, endothelium, epithelium, lymphocytes, etc.
The evaluation of the transcript levels of some 
xenobiotic-metabolizing enzymes is a valuable 
tool for the assessment of exposure to specific 
environmental pollutants. These biomarkers com-
prise phase I and II enzymes, such as members 
of the cytochrome P450 (CYP450) superfamily 
and conjugating enzymes. Phase I metabolism 
consists of a series of oxidative reactions that 
biotransform the parent compound into bioactive 
or detoxified metabolites. The transcriptional 
regulation of CYP1A1 is a typical biomarker of 
exposure to PAHs that has been widely used in 
environmental biomonitoring (15). The induction 
of CYP1A1 is initiated by the ligand binding to 
the aryl hydrocarbon receptor (AhR) and its 
translocation into the nucleus. There, AhR forms 
a heterodimer with the aryl hydrocarbon receptor 
nuclear translocator (Arnt) and binds to xenobiotic 
response elements (XRE) located in the promoter 
region of target genes, including CYP1A1, CYP1A2 
and CYP1B1, promoting gene transcription (59).
CYP1A1 induction by exposure to PAHs, 3-methyl-
cholanthrene and 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD) has been used for the assessment 
of exposure to these compounds in several 
vertebrate models (60-62) and cell lines (61,63,64). 
Moreover, CYP1A1 transcript upregulation has 
been described in various experimental models 
exposed to airborne PM (65), DEPs (54,55,66) 
and cigarette smoking (67-69). Alternatively, the 
CYP1B1 transcription regulation is also postulated 
as a sensitive biomarker of ambient pollution 
(15) because increased mRNA levels have been 
documented in the presence of PAH mixtures 
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(63,64), BaP (61,63,70), TCDD (61,71), PM 
(72), DEPs (54,55,73,74) and tobacco smoking 
(58,68,69) as well.
Other phase I enzymes mostly reported to 
be upregulated at the transcriptional level by 
environmental toxicants are CYP1A2 (55,75) and 
various aldo-keto reductases (AKR). AKRs are 
a family of soluble NAD(P)H oxidoreductases 
that catalyze the metabolisms of a wide range of 
compounds, such as PAHs, aldehydes and drugs. 
AKRs have been associated with exposure to 
tobacco smoke (52,58,68), quinones derived from 
diesel exhaust (DE) (76), BaP and TCDD (61,70).
On the other hand, phase II metabolism involves 
conjugation reactions to increase chemical hydro-
philicity for ease of excretion and elimination of 
possible reactive metabolites. The phase II meta-
bolizing enzymes comprise mainly transferases, 
including UDP-glucuronosyltransferases (UGT), 
sulfotransferases (SULT), N-acetyltransferases 
(NAT), and glutathione S-transferases (GST), 
among others (77). At the transcriptional level, the 
most inducible phase II genes by environmental 
pollutants are the UGTs (72,78) and GSTs 
(54,55,72,74). Other phase II enzymes, such 
as the NAD(P)H: Quinone oxidoreductase-I 
(NQO1) and heme oxygenase-1 (HO-1) genes, 
are also upregulated by a wide range of airborne 
contaminants (55,56,58,61,69,72,74,79).
A master transcriptional regulator for the expression 
of antioxidant and phase II detoxifying genes is 
nuclear factor erythroid 2-related factor 2 (Nrf2). 
Nrf2 is a transcription factor that recognizes specific 
DNA elements known as antioxidant response 
elements (ARE) located in the enhancer region 
of target genes, such as GST subunits A1 and A2, 
NQO1, HO-1, UGTs and others (80). As expected 
and associated with the upregulation of phase II 
enzyme transcription by atmospheric pollutants; 
also, Nrf2 is also robustly induced by these contami-
nants. Nrf2 transcriptional activity and expression 
is increased in the presence of airborne particulate 
matter (79), BaP and TCDD (61), and cigarette 
smoke (67). Moreover, it has been suggested that 
the mechanisms of Nrf2 activation by BaP in HepG2 
cells depends on the metabolic transformation 
of the parent compound and subsequent ROS 
generation (unpublished data).
Additionally, the exposure to DE or ultrafine carbon 
particles (UFP) in experimental chambers has 
provided useful information about transcriptional 
activation in human volunteers. DE is a model 
to study the effects of airborne particles, and 
the UFP are suggested as main causative agent 
of the adverse effects of airborne pollutants. 
Peripheral blood leukocytes are the human tissue 
of study due to their availability, their inflammatory 
response activation following PM exposure and 
their role as cell messengers from the site of entry 
of the pollutants to the rest of the organs (81,82). 
Human exposure to DE induced the activation of 
oxidative stress (82,83), inflammation (83), and the 
proteasome and coagulation cell pathways (82), 
as well as UFP-activated pathways associated 
with inflammation, growth factors, NrF2-mediated 
oxidative stress and xenobiotic metabolism (81).
Somatic cell mutations. A somatic cell mutation 
is any change in the genomic DNA caused by 
internal factors, such as natural errors produced 
during replication or endogenous agents, or by the 
action of environmental mutagens (84). The index 
of mutations can be estimated via the study of 
reporter genes, and the most frequently used is the 
HPRT gene.
HPRT is an X-linked gene that encodes 
hypoxanthine-guanine phosphoribosyltransferase 
(HPRT), an enzyme involved in the phospho-
ribosylation of guanine and hypoxanthine as well 
as purine analogues, such as 6-thioguanine (TG), 
6-mercaptopurine and 8-azaguanine, which require 
this metabolic step to exert their cytotoxic effects 
(85). Two different methods have been developed 
for the assessment of in vivo HPRT mutations, an 
auto-radiographic and a clonal assay. 
The first method has time and cost advantages, but 
it is unable to detect the origin of the mutational 
phenotype of the cells. The cell model of study is T 
lymphocytes, which are cryopreserved, followed by 
stimulation for cell division with phytohemagglutinin 
(PHA) for 3H-thymidine incorporation in selection 
media containing TG. Only mutant cells (HPRT-) 
are able to incorporate 3H-thymidine and TG, while 
normal cells (HPRT+) are sensitive to TG and do 
not synthesize DNA. After the isolation of cellular 
nuclei, they are fixed and autoradiographed, and 
variant frequencies are scored (86). 
On the other hand, the clonal assay allows the 
isolation, clonal expansion and characterization of 
the mutant cells. Isolated T lymphocytes are activated 
with PHA and seeded in microplates containing 
HPRT-deficient feeder cells (B-lymphoblastoid 
cells) in media supplemented with T cell growth 
factor in the presence or absence of TG. The cell 
density to be seeded in each plate depends on TG 
321
Biomédica 2016;36:309-35 Molecular biomarkers assays
supplementation; TG-containing wells receive a 
high cell density for the growth of rare HPRT- cells 
(105 cells/well), but wells without TG will receive 
approximately one cell/well. Cells are incubated 
for 10-14 days and the colonies are characterized 
by either microscopy, 3H-thymidine incorporation 
or cell expansion (86). Furthermore, TG-resistant 
cells may be assayed for HPRT enzymatic activity, 
expression of surface markers and for genomic 
DNA changes.
Accordingly, variant frequencies (VF, autoradio-
graphic method) and mutant frequencies (MF, 
cloning assay) have been determined in different 
populations, and it has been determined that both 
parameters increase with the age of the individuals 
(86,87). Several exposure situations also increase 
the parameters of VF and MF in the HPRT gene, 
such as accidental irradiation, radiotherapy and 
chemotherapy (84). Smoking significantly increases 
VF and MF in active smokers compared with 
former or never smokers, and an association was 
found between cotinine levels and the number of 
smoked cigarettes in this VF (87,88); however, this 
association has not always been found (85). For 
instance, in utero exposure to cigarette smoke was 
not associated with an increased MF in newborns 
(89). However, the study of the in utero exposure to 
environmental pollutants in a highly polluted Polish 
city showed an increased level of DNA adducts in 
the fetus in correlation with an augmented MF, an 
association that was not found in the mothers (90). 
Similarly, the occupational exposure to DE did not 
show an increased MF in the HPRT gene in bus 
mechanic maintenance workers, but there was a 
correlation between MF and adduct levels in the 
most heavily exposed individuals (91). The exposure 
to moderate and low environmental pollution, 
as well as the occupational exposure to PAHs, 
however, did not reflect a statistical association 
with HPRT MF (92). Consequently, HPRT mutation 
frequency is not considered a sensitive biomarker 
of exposure to genotoxicants, but it can be valuable 
in chemoprevention programs for individuals with 
a known exposure risk (85).
Epigenetic biomarkers. Epigenetics is the study of 
hereditary gene expression modifications that do not 
involve a DNA sequence change (93). Three main 
mechanisms of epigenetic control in mammalian 
cells have been described: 1) DNA methylation, 2) 
histone modifications, and 3) microRNA (miRNAs). 
It is well established that many environmental 
factors are able to modify the epigenome of 
an organism as an adaptive response. These 
epigenomic modifications are persistent and, in 
some cases, impact future generations. Therefore, 
the epigenomic “imprinting” of an organism reflects 
its previous exposure to a given contaminant and its 
response capacity to environmental stressors (94).
There are some challenges for epigenetic inves-
tigations that studies need to overcome to draw 
confident conclusions. The main limitation in 
the study of environmental epigenetics is that 
modifications in the epigenome may be negligible 
but cumulative, and their manifestation could be 
evident only after a considerable period of time 
(95,96). However, the number of publications in 
environmental epigenetics is constantly growing 
but lags far behind in comparison with cancer 
epigenetics, for instance (97). The second challenge 
is the accessibility of the appropriate target tissue 
or even the cell type. It is well known that genomic 
DNA is practically identical in any cell type of an 
organism, but the epigenomic profile of each cell 
may be unique and constantly changing (97,98). 
Therefore, the precise selection of a target or 
a surrogate tissue, its availability, and even the 
separation and classification of specific cell types 
may be crucial for the success of the study.
DNA methylation. DNA methylation consists 
of the addition of a methyl group to the fifth 
carbon of a cytosine residue present in regions 
enriched with the dinucleotide CpG, known as 
“CpG islands”. This process is catalyzed by DNA 
methyltransferases (DNMT), enzymes that are 
either constitutively active (DNMT1) or inducible 
(DNMT3A and 3B). Some CpG islands are 
located in the promoter region of protein-coding 
genes, and their hypermethylation is generally 
associated with gene transcription suppression. 
Nevertheless, most of the CpG dinucleotides (90%) 
are located in repetitive transposable elements 
that are generally heavily methylated (99). DNA 
methylation is associated with natural processes, 
such as DNA imprinting, chromosome stability 
and X-chromosome inactivation, but in aberrant 
situations, it is associated with cancer and the 
silencing of tumor suppressor genes (100).
The evaluation of DNA methylation is possible from 
many different biological samples, such as urine, 
plasma, sputum, lymphocytes, buccal cells, saliva, 
and tissues (96), and some technological advances 
have been developed for the analysis of DNA 
methylation from very small amounts of a sample. 
Nevertheless, there is some debate about the 
usefulness of surrogate tissues, such as peripheral 
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blood, in the study of epigenetic modifications 
in target tissues (98). Several approaches are 
available for the study of gene-specific or genome-
wide analysis of DNA methylation status. In the 
first type of procedures, the most popular method 
consists of the conversion of unmethylated cyto-
sines to uracils using sodium bisulfite, leaving the 
methylated residues without any change. This 
technique is followed by different approaches to 
identify the specific methylated DNA region. PCR 
amplification with specific primers directed to the 
methylated DNA sequence, called methylation-
specific PCR (MSP); combined bisulfite conversion 
restriction analysis (COBRA) that identifies restric-
tion enzyme sites that have been preserved or lost 
after bisulfite conversion, and DNA sequencing by 
the Sanger method or pyrosequencing are some 
methodologies used for the identification of specific 
DNA-methylated regions (96,101).
Some methods for the identification of global 
DNA methylation content are high performance 
capillary electrophoresis (HPCE) and HPLC-MS 
after DNA digestion to single oligonucleotides 
(96,101). The evaluation of methylation levels 
of transposable highly repetitive sequences in 
DNA is another method to estimate genome-
wide methylation levels. The multiple repetition 
elements Alu and LINE-1 (long interspersed 
nuclear element-1) are two well-characterized 
elements that normally are heavily methylated, and 
any decrease in their methylation degree indicates 
a change in the whole-genome methylation status 
(99). Likewise, different genome-wide methylation 
platforms are based on microarrays and combine 
different technologies, such as immunoprecipita-
tion of 5-methylcytosine with specific antibodies 
(methylated DNA immunoprecipitation or MeDIP), 
methylation-sensitive restriction enzymes and 
PCR amplification, bisulfite treatment coupled 
with hybridization to microarrays, and sequencing, 
among others.
The modification of the DNA methylation profile in 
individuals exposed to environmental contaminants 
is the most studied epigenetic modification due to 
the relative stability of methylation, to the multiple 
technical approaches that are available for its 
study (98) and to the feasibility to preserve DNA 
samples in comparison to chromatin and RNA 
(97). Metals such as nickel, cadmium, lead and 
arsenic are recognized for their capacity to alter 
the methylation profile of DNA (102). Ambient air 
pollution is associated with the hypermethylation 
of the forkhead box transcription factor 3 (FOXP3) 
and is involved in asthma pathogenesis (103,104); 
specifically, the exposure to particulate matter (PM 
2.5), black carbon and sulfates produces global 
DNA hypomethylation (assessed by methylation 
levels of ALU and/or LINE1) (105,106) as well as 
aberrant methylation levels in the promoter of the 
inducible nitric oxide synthase (iNOS) (107-109). 
In mouse models acutely exposed to inhaled DEP 
or particulate air pollution, hypermethylation of 
different CpGs in the interferon gamma (IFN-γ) 
promoter and hypomethylation at one CpG island 
in the interleukin (IL)-4 promoter (110), as well as 
persistent hypermethylation of sperm DNA (111), 
were found, respectively.
The exposure to PAHs is also related to an 
increase in global methylation levels of DNA, 
to the hypermethylation of cytokine IL-6 and 
to p53 hypomethylation in coke-oven workers 
(112). In neonates, PAH exposure induces the 
hypermethylation of 5ˈ-CpG islands of acyl-CoA 
synthetase long-chain family member 3 (ACSL3) 
(113) and IFN-γ (114) in white blood cells extracted 
from the umbilical cord. In firefighters, the level 
of dual specificity phosphatase 22 (DUSP22) 
promoter methylation decreases in relation to the 
years of service, an effect that is reproduced with 
BaP at low doses (115).
Histone modifications. The post-translational modi-
fication of the amino-terminal tail domains of 
histones is another important mechanism of 
epigenetic regulation. Histones are globular proteins 
that fold, organize and compact DNA in structural 
units called nucleosomes that form chromatin. The 
nucleosome is a histone octamer consisting of one 
H3-H4 tetramer and two H2A-H2B dimers, and the 
histone H1 acts as a linker (116).
Several mechanisms regulate histone function, 
and these proteins are highly dynamic actors in 
gene regulation. Histone modifications comprise 
methylation, acetylation, phosphorylation, ubiqui-
tination, sumoylation, citrullination and ADP-
ribosylation (95); enzymes such as histone 
acetyltranferases (HAT), deacetylases (HDAC), 
methyltransferases, and demethylases are involved 
in these processes. The methylation, acetylation 
and phosphorylation status of specific amino-
terminal tail domains of histones defines chromatin 
structure and gene expression. In general terms, 
histone hyperacetylation is associated with loosely 
packed chromatin or euchromatin and gene 
transcription. On the other hand, hypoacetylated 
and hypermethylated histones generate condensed 
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chromatin or heterochromatin and are associated 
with methylated DNA and transcriptional silencing 
(101,116). Nevertheless, the “histone code 
hypothesis” indicates that specific histone modi-
fication patterns, present at specific residues, 
determine the overall activation or repression of 
gene transcription (116).
Several histone modifications have been analyzed 
in cell lines (117-119) and peripheral mononuclear 
cells (120), blood leukocytes (121) and respiratory 
epithelia (122) from different human populations. 
The methodologies applied for these studies include 
genome-wide and gene-specific approaches. The 
most accurate method for the identification of 
histone modifications is MS, but the combination 
of other methods such as HPLC, HPCE or Western 
blotting can also be applied to identify histone 
modifications globally (101). Recently, ELISA kits 
have been developed and are being used for the 
analysis of specific histone modifications (120,121). 
The most popular current method for the study 
of single gene-associated histone modifications 
is chromatin immunoprecipitation (ChIP) (117-
119,122) that uses specific antibodies against 
histone chemical markers and a primer-specific 
PCR for a candidate gene. For the genome-wide 
study of histone modifications, ChIP-on-chip is a 
platform that allows the detection of patterns of 
histone modifications and combines the use of 
antibodies against histone modifications with a 
DNA array (101).
There is strong evidence that environmental factors 
lead to histone modification changes and, therefore, 
to gene transcription modulation. The most studied 
environmental stressors that modify histone 
patterns in different models are metals such as 
nickel, cobalt, arsenic and chromium. For instance, 
nickel is associated with many histone modifications 
in H2, H3 and H4 by methylation, acetylation, 
phosphorylation and ubiquitination, whereas arsenic 
is related to methylation modifications in H3 and 
acetylation in H4, and, finally, chromium and cobalt 
are associated with H3 methylation at different lysine 
residues. In a Chinese population occupationally 
exposed to nickel, elevated levels of H3K4me3 
(histone 3, lysine 4 trimethylation) and reduced 
H3K9me2 (histone 3, lysine 9 dimethylation) were 
found in blood mononuclear cells (120). Moreover, 
in peripheral blood leukocytes from steel workers 
exposed to PM enriched in metal particles, two 
histone modifications associated with open actively 
transcribed chromatin, H3K4me2 (histone 3, lysine 
4 dimethylation) and H3K9ac (histone 3, lysine 9 
acetylation), were increased and correlated with 
the years of service (121). With respect to some 
environmental pollutants, DE particulate matter 
caused an overregulation of the pro-inflammatory 
mediator cyclooxygenase-2 (COX-2) via the hyper-
acetylation of histone H4 and recruitment of p300 
HAT to the COX2 promoter and degradation 
of HDAC1 in a human bronchial epithelial cell 
line (BEAS-2B) (117). In addition, in A549 cells, 
PM10 exposure increased the levels of the pro-
inflammatory cytokine IL-8 via an increase in 
H4 acetylation of the IL-8 promoter region (118). 
Additionally, BaP and cigarette smoke condensate 
(CSC) exposures were associated with an increase 
in the transcriptionally active H3K4me3 and H3K9ac 
chromatin indicators in HeLa cells and normal 
human respiratory epithelia, respectively (119,122).
MicroRNAs. MicroRNAs (miRNAs) are short 
non-protein coding single-stranded RNAs that 
interfere with the translation of complementary 
mRNAs or induce their degradation (95). miRNAs 
are transcribed by RNA polymerase II as primary 
miRNAs (pri-miRNAs) containing a 5ˈ-capping and 
a 3ˈ-polyadenylation tail. In the nucleus, the pri-
miRNA is processed by RNase III Drosha/DGCR8 
into a precursor miRNA (pre-miRNA), which is then 
exported to the cytoplasm by exporting 5/RAN-
GTP. The RNase III Dicer complex processes the 
pre-miRNA into a mature single-stranded miRNA 
of approximately 20 nucleotides in length, which is 
incorporated into the RISC (RNA-induced silencing 
complex). Mature miRNAs regulate mRNAs 
expression by two different mechanisms according 
to its complete or incomplete complementarity to 
the target mRNA. The complete complementarity 
leads to the degradation of the target mRNA; on 
the other hand, incomplete complementarity leads 
to translation inhibition (100).
The evaluation of miRNA levels as a molecular 
biomarker has many advantages: 
1) miRNAs are considered less complex compared 
to proteins; 
2) they do not accumulate modifications after their 
processing; 
3) different molecular tools are available for their 
isolation, and 
4) they can be easily and sensitively detected by 
PCR-based technologies. 
Nevertheless, there are still some challenges to 
overcome before miRNAs can be used as good 
biomarkers of exposure. For instance, the technical 
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procedure should be standardized in terms of 
sample storage, collection and transportation, as 
well as miRNA extraction, detection, normalization, 
reproducibility, validation and analysis (123,124). 
The identification of miRNA targets is another 
limitation that has to be overcome to elucidate 
the biological function of specific miRNAs (124). 
According to their mechanisms of action, each 
miRNA may present incomplete complementarity 
with several target mRNAs and therefore regulate 
the expression of numerous transcripts and vice 
versa, as one mRNA can be modulated by many 
miRNAs. The available tools for the identification 
of potential miRNA targets comprise computational 
and experimental approaches (124).
The most widely used technique for miRNA 
detection is the miRNA microarray for genome-
wide screening and real-time PCR for gene-specific 
approaches, but sequencing is also being used, 
albeit less frequently. miRNAs have been assessed 
in cell lines (125), human primary cell cultures 
(126-128), human peripheral blood leukocytes 
(129), tissues (122,130,131) and different body 
fluids (123,132,133). The latter surrogate samples 
have been widely used in oncology studies due to 
miRNA localization in microparticles and exosomes 
that confer high stability (123). Accordingly, serum, 
plasma, urine, amniotic fluid, and sputum, among 
others, can be used for miRNA analysis. 
Some studies have highlighted the sensitivity of 
miRNAs to respond against environmental insults 
and their usefulness as powerful biomarkers of 
exposure and for biomonitoring and prevention. 
miRNA expression has been linked to exposure to 
environmental stressors, and altered miRNA levels 
have been associated with exposure to ambient 
particulate matter (127), DE and DEP (126,127), 
metals (129,133), cigarette smoke (122,125,134), 
asbestos (128), carbon black nanoparticles (131), 
ozone (132) and others.
Metals such as arsenic, cadmium, aluminum 
and lead alter miRNA expression (124,129). For 
instance, exposure to residual oil flay ash (ROFA), a 
fine particle product from oil combustion containing 
transition metals such as Ni, V and Fe, elicited 
cardiac dysfunction and altered miRNA expression 
levels in hypertensive rats (130). The study 
performed by Bollati, et al. (2010), in peripheral 
blood leukocytes from a population of steel workers 
exposed to metal-rich particulate matter also 
identified overexpression of two miRNAs related 
to oxidative stress and inflammation regulation 
(miR-222 and miR-21) in exposed individuals. 
Furthermore, the expression of miR-222 was 
directly correlated with exposure to lead, and miR-
146a expression was inversely correlated with lead 
and cadmium (129). Other upregulated miRNAs in 
workers exposed to metal-rich PM were miR-421, 
miR-146a, miR-29a and let-7g (133).
DE particles, likewise, were associated with the 
modification in expression levels of 197 out of 
313 miRNAs identified in human airway epithelial 
cells, some of which are associated with the 
inflammatory response and tumorigenic processes 
(126). Human microRNA-375 is one of the miRNAs 
upregulated following exposure to DEP and ambient 
PM and possibly regulates the expression of the 
AhR receptor (127). Furthermore, BaP exposure 
upregulated the expression of miR-320 and miR-
494 and was associated with cell cycle progression 
and tumorigenesis in murine bronchial epithelial 
cells (135); however, the in vivo BaP exposure does 
not significantly modify hepatic miRNA expression 
regardless of marked changes in mRNA transcrip-
tion in mice (136). Other environmental pollutants, 
such as hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX), 
caused modulation of several miRNAs associated 
with cancer and tumor suppression in mouse brain 
and liver (137).
Susceptibility biomarkers
It is well documented that the development of 
adverse health effects by exposure to different 
environmental factors is determined by the sus-
ceptibility of each individual. These susceptibility 
factors are cataloged as genetic predisposition, age, 
gender and ethnicity (138). The balance between 
exposure time and dose with susceptibility factors 
determines individual biological response and the 
risk for disease development. 
In terms of the influence of chemical pollutants on 
human health, the participation of genes encoding 
metabolic or detoxification enzymes plays a key role 
in the genetic susceptibility to xenobiotics; however, 
genes associated with DNA damage repair likewise 
predispose individuals to a susceptibility phenotype 
against toxicological insults. The biomarkers of 
susceptibility most frequently used are the genetic 
polymorphisms located in metabolic genes asso-
ciated with phase I and II metabolizing enzymes.
Genetic polymorphisms
Genetic polymorphisms are natural occurring 
variations in DNA sequence with a frequency equal 
to or higher than 1% in the general population 
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(139). A polymorphism may be located in coding 
or non-coding sequence, and they might be “silent” 
or “functional” if the polymorphism impacts the 
activity, stability and/or expression levels of a 
protein. Some of the effects of a polymorphism 
in the expression of a gene are: 1) Amino acid 
substitution, 2) duplication, 3) deletion, 4) protein 
variants, 5) modulation of the expression levels, and 
6) modification of RNA splicing and stability (139). 
Single nucleotide polymorphisms (SNP) are a 
case in point and consist of the substitution of a 
single base pair, resulting in variants of the same 
gene or alternative alleles (140). SNPs are the 
most frequent type of polymorphisms in humans, 
accounting for approximately 90% of them (140). 
SNP identification is possible from different human 
samples, and venous blood is the tissue sample 
of choice; however, specific blood cell populations 
are used, for example leukocytes (141,142), 
lymphocytes (143-145) and the mononuclear 
fraction (146), and tissues such as placenta (20), or 
even buccal cells (147,148) are also appropriate for 
genotyping. Several methods have been developed 
for their identification, with DNA sequencing being 
the gold standard (149). The most common method 
for SNP analysis uses restriction endonucleases in 
cases where the polymorphism creates or destroys 
a specific nucleotide recognition sequence for 
a restriction enzyme (restriction fragment length 
polymorphism or RFLP). Other useful methods are 
real-time PCR using TaqMan probes (13,148,150), 
and primer extension-based methods (145,151,152) 
(table 3).
SNPs are the polymorphisms most widely studied 
in terms of genetic susceptibility to environmental 
pollutants (table 4). The study of genetic poly-
morphisms present in enzymes associated with the 
biotransformation of toxicants has provided relevant 
susceptibility biomarkers in toxicology (153). 
The cytochrome P450 enzymes are the primary 
proteins involved in phase I metabolism, and some 
members of this family are highly polymorphic. For 
instance, CYP2B6 is one the most polymorphic 
CYP members, with 102 allelic variants identified 
so far (15). Because CYPs are the first enzymatic 
barrier that responds to a xenobiotic exposure in 
the organisms, the study of genetic variations 
that may impact CYP expression levels, function 
and efficiency is crucial for the identification of 
individuals with altered enzymatic activity that may 
be predisposed to adverse health effects in the 
presence of environmental stressors.
Phase I enzymes. CYP1A1 polymorphisms are 
the most studied variants in terms of human 
genetic susceptibility (15). The variant CYP1A1*2A 
(T3801C) in the 3ˈ non-coding region, which 
generates an Msp1 restriction site, has been linked 
to a variety of outcomes related to exposure to 
different types of environmental pollutants. The 
presence of this polymorphism is associated with 
an increased urinary 1-OHP concentration related 
to air pollution (12), PAH exposure (10) and light 
tobacco consumption (154). Individuals carrying 
the CYP1A1*2A allele are predisposed to higher 
DNA adduct levels and an increased percent of 
aberrant cells when exposed to environmental 
tobacco smoke (ETS) (144). Likewise, in an Asian 
population, the presence of the MspI polymorphism 
correlated with reduced birth weight following high 
PM10 exposure (155), oral cancer risk associated 
with tobacco smoking and chronic obstructive 
pulmonary disease (156).
Additionally, the variant CYP1A1*2B or 2C 
(A2455G), which has an amino acid substitution of 
Ile462 to Val in exon 7, has been associated with 
higher 1-OHP (9,12,13), 2-NT (9), DNA damage 
(13) and PAH-DNA adducts (157) in high PAH or 
tobacco smoking populations, as well as reduced 
birth weight in pregnant women exposed to high 
PM10 levels (155). The interaction of smoking or 
Table 3. Susceptibility biomarkers. Environmental compounds associated with genetic polymorphisms, techniques used for 
polymorphism analysis and surrogate tissues for analysis
Susceptibility biomarkers
Environmental compounds Methods for identification Types of samples
Polymorphisms PAH
Tobacco smoke
High PM exposure
DNA sequencing
RFLP
Real time PCR-TaqMan
DNA microarrays
Primer extension-base technologies 
Venous blood
Lymphocytes
Leukocytes
Placenta
Buccal cells
PAH: polycyclic aromatic hydrocarbons; PCR: polymerase chain reaction; PM: particulate matter; RFLP: restriction fragment length 
polymorphism
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ETS with the CYP1A1 (Ile462Val) polymorphisms 
and their association with adverse health effects 
is controversial. Because, while cervical cancer 
development has shown a significant association 
(142), others like lung cancer (150) and asthma 
development in children (158) did not. Both 
variants, CYP1A1*2A and CYP1A1*2B, have been 
associated with a higher enzymatic induction and/
or enhanced catalytic activity and are correlated 
with an increased risk of several types of cancer; 
therefore, these polymorphisms are useful sus-
ceptibility biomarkers for PAH exposure and 
carcinogenesis (15).
In addition, other family members of the CYP450s 
have been reported as polymorphic and have 
shown interactions with environmental pollutants. 
Among them, CYP2E1, a cytochrome associated 
with the metabolism of alcohol, acetone, benzene, 
toluene, styrene and nitrosamines, has at least 34 
variants (159). The CYP2E1 RsaI polymorphism is 
associated with increased urinary levels of 1- and 
2-NTs (14,160), and 1-OHP (14), as well as with 
higher DNA adduct levels in human lung tissue 
(161) from PAH-exposed individuals. Nevertheless, 
some studies did not find a correlation of this 
polymorphism with increased PAH metabolic 
products (9,16,162).
Other phase I polymorphic enzymes relevant to 
environmental toxicant metabolism are epoxide 
hydrolase 1 (EPHX1) and AKRs. EPHX1, which 
encodes a protein that catalyzes the addition of 
water to epoxides for their detoxification, presents 
two polymorphic variants, T8668C (Y113H) and 
A15543G (H139R). The former polymorphism 
has been associated with high OHPhe urinary 
levels, whereas the latter was associated with low 
Table 4. Selected polymorphisms and associated health risk
Polymorphism Associated health damage
Phase I enzymes
CYP1A1*2A (T3801C, MspI) Increased PAH metabolites, PAH-DNA adducts and percent of aberrant cells
Reduced birth weight
Chronic obstructive pulmonary disease
Oral cancer risk
CYP1A1*2B (A2455G, I462V) Increased PAH metabolites, PAH-DNA adducts and DNA damage
Reduced birth weight
Cervical and lung cancer risk
CYP2E1 (RsaI) Increased PAH metabolites and DNA adduct levels
EPHX1 (T8668C, Y113H) Increased PAH metabolites (HH homozygotes)
EPHX1 (A15543G, H139R) Increased DNA adduct levels (HH homozygotes, WT)
AKR1C3*2 (Gln5His) Lung cancer risk
Phase II enzymes
NAT2 rapid acetylators Increased oxidative DNA damage
Lung and breast cancer risk
NAT2 slow acetylators Increased PAH metabolites and DNA adduct levels
Bladder, urothelial and breast cancer risk
GSTM1 null Increased PAH metabolites, DNA adduct and higher oxidative DNA damage
Preterm delivery
Lung cancer risk
GSTT1 null Acute leukemia
Coronary artery disease
Lung cancer risk
GSTP1 (C3517T, A114V) Increased PAH metabolites
DNA repair genes
XRCC1 R339Q
ERCC1 N118N
XRCC3 T241M
Malignant mesothelioma (asbestos exposure)
OGG1 S326C Higher oxidative DNA damage
Lung cancer risk
XPD23 K751Q Higher levels of DNA breaks
XPC (PAT +) Higher DNA adduct levels
AKR: aldo-keto reductase; EPHX: epoxide hydrolase; ERCC: excision repair cross-complementing; GST: glutathione S-transferase; NAT: 
N-acetyltransferase; OGG1: 8-oxo-guanine-DNA glycosylase/AP lyase; PAH: polycyclic aromatic hydrocarbons; XPC (PAT+): Xeroderma pigmentosum-C 
polyAT insertion of 83 bp in intron 9; XPD23: exon 23 variant of the Xeroderma pigmentosum-D; XRCC: X-Ray cross-complementing
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OHPhe levels in German workers exposed to 
PAH in homozygous carriers (143). Accordingly, 
the lower levels of PAH metabolites observed in 
the homozygous 139RR mutant can be correlated 
with the higher DNA adducts levels observed in 
lymphocytes from EPHX1 139HH (WT) individuals 
(163). 
From the AKR family, the variant AKR1C3*2 
(Gln5His) has been associated with increased 
lung cancer susceptibility in a Chinese population 
exposed to PAH-rich smoky coals (164); never-
theless, there was an inverse correlation between 
this polymorphism and bladder cancer risk in 
Caucasians (165) and no relation with mRNA levels 
of different AKRs (AKR1A1, AKR1C1-AKR1C3) in 
smokers (52).
Phase II enzymes. NATs (NAT1 and NAT2), the 
key enzymes in the conjugation of arylamine 
compounds, display a high inter-individual varia-
bility in their capability to acetylate certain drugs, 
leading to the classification of individuals as fast, 
slow and intermediate “metabolizers” (77,166). 
Thirty-six NAT2 polymorphic variants have been 
described in humans (166). NAT2*4, the wild-
type allele, is the fast acetylation variant, although 
variants such as NAT2*12 and NAT2*13 are also 
associated with the rapid acetylator phenotype in 
some populations. Several alleles are associated 
with the slow acetylator phenotype, and the most 
common ones are NAT2*5, NAT2*6, NAT2*7 
and NAT2*14, which contain one or more of the 
G191A, T341C, A434C and G590A polymorphisms 
(166). The slow acetylator genotype has been 
associated with a higher risk of bladder cancer 
by exposure to arylamine pollutants from tobacco 
smoke, occupational exposure to benzidine-based 
dyes, or by alcohol intake; higher risk of urothelial 
cancer of the renal pelvis in dinitrotoluene-exposed 
workers; and an increased risk of breast cancer 
in postmenopausal smoking women and in non-
smoker women exposed to ETS for long periods 
(148,153,166). Likewise, the NAT2 slow genotype 
has been associated with higher DNA adduct levels 
(21) and higher urinary PAH metabolites (167) in 
occupational and non-occupational PAH-exposed 
populations. On the other hand, the NAT2 fast 
acetylator genotype was associated with higher 
8-OHdG levels by tobacco smoking and PAH 
exposure (16) and predisposed carriers to lung 
cancer (168) and breast cancer in the case of long-
time heavy smoker women (148). NAT1 allelic 
variants have also been described (26 alleles in 
humans), but their functional effects have been 
less studied; nevertheless, the variant NAT1*10 
(associated with a fast acetylation phenotype) was 
related to an increased risk of bladder cancer in 
smokers (166). 
Different classes of GST polymorphisms are 
associated with increased levels of health risks 
according to the modification of several biomarkers 
of exposure and effect to environmental pollutants. 
From them, the GSTM polymorphism GSTM1*0, 
which results in a deleted allele of high prevalence 
between populations, is associated with higher 
levels of urinary 1-OHP (8,13), 1- and 2-NT 
(14,160), 8-OHdG (169-171) and DNA adduct levels 
(17,20,167,172,173). Moreover, it is considered a 
risk factor for preterm delivery in association with 
exposure to PM10 (174). Conversely, the GSTT null 
mutant is neither associated with increased urinary 
1-OHP levels (12,13) nor higher urinary 8-OHdG 
(169) or DNA adduct concentrations (163), but it 
has been linked to a higher predisposition for acute 
leukemia in Chinese children living in proximity to 
industrial plants (151) and coronary artery disease in 
smokers (141). As for the GSTP polymorphisms, the 
A2627G genotype (I105V) is related to an increase 
(162) or decrease in the urinary 1-OHP levels (12) 
in occupational exposed workers. Notwithstanding, 
the genotype GSTP1 C5317T (A114V) was related 
to higher urinary 1-OHP and OHPhe in German 
workers with high PAH exposures (143).
DNA repair gene polymorphisms. Polymorphisms 
present in DNA repair genes are also considered 
variability factors that predispose individuals 
to health outcomes in high-risk situations of 
toxicological exposure. High asbestos pollution, 
for instance, is associated with malignant 
mesothelioma, and the individuals who carry the 
variants 399Q of XRCC1, N118N of ERCC1 and 
241T of XRCC3 are at increased risk for disease 
development (145,152). Other DNA repair gene 
polymorphic variants reported as susceptibility 
factors are: 8-oxo-guanine-DNA glycosylase/AP 
lyase (hOGG1) 326C, that correlates with higher 
oxidative DNA damage in bus drivers exposed 
to PAHs and volatile compounds (146) and with 
increased risk for lung cancer by indoor PAH 
exposure (164); exon 23 variant of the Xeroderma 
pigmentosum-D (XPD) A35931C Lys751Gln, that 
induces higher levels of DNA strand breaks in the 
aforementioned population (146), and Xeroderma 
pigmentosum-C (XPC) polyAT insertion of 83 bp 
in intron 9 (PAT+), that associates with higher 
anti-BPDE-DNA adducts under low (172) and high 
levels of PAH exposure (173).
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Gene-gene interactions. Finally, multiple gene-
gene interactions with environmental pollutants 
have been observed in individuals carrying more 
than one polymorphism, leading to an extremely 
complex scenario of genetic susceptibility. Genetic 
interactions are observed with the CYP1A1*2A 
(MspI) polymorphism and a variety of phase 
II enzymes. The interaction of the CYP1A1*2 
polymorphism with the GSTM1 null, GSTP1 (Ile/
Val) and the EPHX “slow” variants results in higher 
DNA adduct levels (24,163). The combination of 
the GSTM1 null with the NAT2 slow acetylator 
genotype correlates with higher urinary PAH 
metabolites (167) as well as increased CAs (175) 
in individuals exposed to rich PAH environments. 
Likewise, an increased risk for lung and breast 
cancer has been found in individuals carrying 
the GSTM1 null, GSTT1 null and the NAT2 rapid 
acetylator genotypes (176,177).
Conclusion
In the present review, we summarized the main 
and extensively used molecular biomarkers applied 
to environmental monitoring for human risk assess-
ment. Some of them are highly associated with the 
exposure condition, while others are not statistically 
significant or display contradictory results. Despite 
the presence of some discrepancies, there is 
cumulative evidence that environmental pollution 
indeed affects several molecular markers, including 
all three biomarker types: exposure, effect and 
susceptibility (table 1).
The usefulness of biomarkers is of great importance 
for studies on risk evaluation and impact to health 
because they provide a platform to offer solutions 
leading to the amelioration of contamination and 
the adverse effects that pollutants produce. Equally 
important is to bear in mind that the response will 
depend on an individual’s genetic background, thus 
the study of polymorphisms in human populations 
will also become useful for accurate interpretations. 
However, some of the issues remain to be 
discussed in depth, such as the selection of the 
most appropriate surrogate tissues for the study 
to produce reliable results with the least invasive 
methods for sample collection. 
As peripheral blood is the surrogate of choice 
for most analyses, the acquisition of precise and 
correct results is still debatable, as blood is neither 
the first contact organ with xenobiotics nor the 
location of pollutant metabolism. Therefore, the 
exploration of new surrogate types of cells or tissues 
should consider the collection methods. The study 
design should also take into account the size of the 
sample required, its susceptibility to cancer and 
the interaction of the surrogate with the xenobiotic 
or its metabolites.
Therefore, with the development of new technolo-
gies and the discovery of novel biomarkers, risk 
assessment evaluation of pollutant exposure should 
comprise a set of biomarkers that includes diverse 
aspects of the individual’s toxicological response 
to integrate the data to dissect the mechanisms 
of action of xenobiotics and target organs and to 
predict adverse health effects.
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